• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺护理模式的转变:多学科环境下影像学的影响

Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.

作者信息

Krishnamurthy Savitri, Bevers Therese, Kuerer Henry M, Smith Benjamin, Yang Wei Tse

机构信息

1 Department of Pathology Administration, The University of Texas M. D. Anderson Cancer Center, Houston, TX.

2 Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX.

出版信息

AJR Am J Roentgenol. 2017 Feb;208(2):248-255. doi: 10.2214/AJR.16.17130. Epub 2016 Dec 8.

DOI:10.2214/AJR.16.17130
PMID:27929664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5482504/
Abstract

OBJECTIVE

The practice of breast imaging in a collaborative multidisciplinary environment adds significant value to outcomes in women's health care. In this article, we describe multidisciplinary considerations in breast cancer screening and early detection, the impact of imaging and histopathologic findings in the diagnostic evaluation and management of breast abnormalities, and the contribution of imaging to surgical and radiation therapy planning for the breast cancer patient.

CONCLUSION

The multidisciplinary delivery of breast care for women that incorporates screening, diagnosis of borderline and high-risk lesions, and management of the breast cancer patient adds considerable value to outcomes in health care.

摘要

目的

在多学科协作的环境中开展乳腺成像实践,可为女性医疗保健的结果增添显著价值。在本文中,我们描述了乳腺癌筛查和早期检测中的多学科考量、成像和组织病理学结果在乳腺异常诊断评估及管理中的影响,以及成像对乳腺癌患者手术和放射治疗规划的贡献。

结论

为女性提供的多学科乳腺护理,包括筛查、临界和高危病变的诊断以及乳腺癌患者的管理,可为医疗保健结果增添相当大的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/5482504/24087e97e22b/nihms864176f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/5482504/4f5114cfb540/nihms864176f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/5482504/24087e97e22b/nihms864176f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/5482504/4f5114cfb540/nihms864176f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/5482504/24087e97e22b/nihms864176f2a.jpg

相似文献

1
Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment.乳腺护理模式的转变:多学科环境下影像学的影响
AJR Am J Roentgenol. 2017 Feb;208(2):248-255. doi: 10.2214/AJR.16.17130. Epub 2016 Dec 8.
2
Section Editor's Notebook: The Future of Breast Imaging-Find It and Fix It.栏目编辑手记:乳腺成像的未来——发现问题并解决问题
AJR Am J Roentgenol. 2017 Feb;208(2):245-247. doi: 10.2214/AJR.16.17591.
3
Breast cancer management in the new millennium--a multidisciplinary approach.新千年的乳腺癌管理——一种多学科方法。
S Afr Med J. 2003 Nov;93(11):804-5.
4
Molecular Breast Imaging for Screening in Dense Breasts: State of the Art and Future Directions.用于致密乳腺筛查的分子乳腺成像:现状与未来方向
AJR Am J Roentgenol. 2017 Feb;208(2):275-283. doi: 10.2214/AJR.16.17131. Epub 2016 Oct 20.
5
Screening breast ultrasound: past, present, and future.乳腺超声筛查:过去、现在与未来。
AJR Am J Roentgenol. 2015 Feb;204(2):234-40. doi: 10.2214/AJR.13.12072.
6
[Future of mammography-based imaging].[基于乳腺钼靶成像的未来]
Radiologe. 2014 Mar;54(3):217-23. doi: 10.1007/s00117-013-2578-2.
7
A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center.综合性乳腺中心乳腺癌诊治及时性的质量评价。
J Am Coll Surg. 2010 Apr;210(4):449-55. doi: 10.1016/j.jamcollsurg.2010.01.015.
8
[Mission "Reduction in mortality of the commonest cancer in women"].[使命:降低女性最常见癌症的死亡率]
Radiologe. 2014 Mar;54(3):203-4. doi: 10.1007/s00117-013-2574-6.
9
[Mammography screening in Germany. Current results and future challenges].[德国的乳腺X线筛查。当前结果与未来挑战]
Radiologe. 2014 Mar;54(3):205-10. doi: 10.1007/s00117-013-2581-7.
10
Multidisciplinary considerations in the management of high-risk breast lesions.高危乳腺病变的多学科处理。
AJR Am J Roentgenol. 2012 Feb;198(2):W132-40. doi: 10.2214/AJR.11.7799.

引用本文的文献

1
Immediate and delayed risk of breast cancer associated with classic lobular carcinoma in situ and its variants.经典型乳腺小叶原位癌及其变异型与乳腺癌的即刻和延迟风险。
Breast Cancer Res Treat. 2024 Jun;205(3):545-554. doi: 10.1007/s10549-024-07261-6. Epub 2024 Mar 12.
2
Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.MRI 引导下乳腺活检诊断的乳腺小叶肿瘤:评估升级为恶性肿瘤的比率以及临床和手术管理的结果。
Ann Surg Oncol. 2024 Apr;31(4):2224-2230. doi: 10.1245/s10434-023-14764-x. Epub 2023 Dec 20.
3
Evaluating imaging-pathology concordance and discordance after ultrasound-guided breast biopsy.

本文引用的文献

1
Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia.核心乳腺活检显示小叶原位癌时应行切除术,对不典型小叶增生行监测是合理的。
AJR Am J Roentgenol. 2016 Nov;207(5):1132-1145. doi: 10.2214/AJR.15.15425. Epub 2016 Aug 17.
2
A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.一项关于非放射性手术引导技术在切除不可触及乳腺病变时定位的前瞻性、单臂、多中心临床评估。
Ann Surg Oncol. 2016 Oct;23(10):3168-74. doi: 10.1245/s10434-016-5405-y. Epub 2016 Jul 28.
3
评估超声引导下乳腺活检后的影像-病理一致性和不一致性。
Ultrasonography. 2018 Apr;37(2):107-120. doi: 10.14366/usg.17049. Epub 2017 Aug 19.
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
使用夹闭淋巴结的选择性评估对淋巴结阳性乳腺癌患者新辅助治疗后腋窝评估进行改进:靶向腋窝清扫的实施
J Clin Oncol. 2016 Apr 1;34(10):1072-8. doi: 10.1200/JCO.2015.64.0094. Epub 2016 Jan 25.
4
Addressing overtreatment of screen detected DCIS; the LORIS trial.解决过度治疗筛查出的 DCIS 问题;LORIS 试验。
Eur J Cancer. 2015 Nov;51(16):2296-303. doi: 10.1016/j.ejca.2015.07.017. Epub 2015 Aug 18.
5
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.导管原位癌诊断后的乳腺癌死亡率。
JAMA Oncol. 2015 Oct;1(7):888-96. doi: 10.1001/jamaoncol.2015.2510.
6
Targeting and limiting surgery for patients with node-positive breast cancer.针对淋巴结阳性乳腺癌患者的手术靶向与限制
BMC Med. 2015 Jun 25;13:149. doi: 10.1186/s12916-015-0385-5.
7
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.一项前瞻性、随机、开放标签、国际多中心、III期、非劣效性试验评估低风险导管原位癌主动监测安全性的可行性——LORD研究
Eur J Cancer. 2015 Aug;51(12):1497-510. doi: 10.1016/j.ejca.2015.05.008. Epub 2015 May 26.
8
Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).影响参加美国外科医师学会肿瘤学组Z1071(联盟)试验的乳腺癌患者新辅助化疗后前哨淋巴结识别率的因素
Ann Surg. 2015 Mar;261(3):547-52. doi: 10.1097/SLA.0000000000000551.
9
Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011.术前超声引导下细针穿刺抽吸细胞学检查阳性的原发性乳腺癌患者腋窝淋巴结负荷:ACOSOG Z011时代的管理
Eur J Surg Oncol. 2015 Apr;41(4):559-65. doi: 10.1016/j.ejso.2015.01.011. Epub 2015 Jan 24.
10
Current management of lesions associated with an increased risk of breast cancer.与乳腺癌风险增加相关的病变的当前管理。
Nat Rev Clin Oncol. 2015 Apr;12(4):227-38. doi: 10.1038/nrclinonc.2015.8. Epub 2015 Jan 27.